Download Files:
Products Details
Product Description
– HCV-IN-39 (Compound 18a) is a potent hepatitis C virus (HCV) nucleoside inhibitor with EC50 values of 0.644, 0.952 and 0.154 μM against GT1a, GT1b and GT1b CES1 replicons[1].
Web ID
– HY-147763
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C21H26BrClN3O9P
References
– [1]Chris Krueger A, et al. Synthesis and evaluation of 2′-dihalo ribonucleotide prodrugs with activity against hepatitis C virus. Bioorg Med Chem. 2020 Jan 1;28(1):115208.
CAS Number
– 2087916-31-0
Molecular Weight
– 610.78
SMILES
– CCOC(C(C)(N[P@](OC[C@H]1O[C@H]([C@](Br)([C@@H]1O)Cl)N2C=CC(NC2=O)=O)(OC3=CC=CC=C3)=O)C)=O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– HCV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
